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Bioethics is a hot topic. Few weeks go by without a headline concerning the implications of emerging 
scientific possibilities, health service controversies, or moral dilemmas around death and dying. The 
study and resolution of these problems form part of the field of bioethics. While in some countries 
the discipline has been dominated by philosophers, in the UK lawyers have played a pivotal role. One 
commentator has argued that Professor Sir Ian Kennedy, then at the Law School of King’s College 
London ‘virtually invented the field in the United Kingdom’. Certainly, his Reith Lectures in 1980, 
later published as The Unmasking of Medicine (1983), mark the beginning of highly visible public 
discussions of the issues which became increasingly matters for society to determine whereas they 
had previously been seen as internal matters of professional ethics. While early medical legislation 
displayed such a degree of trust in the profession that no sanctions were included in the Human 
Tissue Act of 1961, now it is subject to extensive regulation. The Human Tissue Act of 2004 begins by 
listing no less than nine activities which constitute crimes unless authorised by an appropriate 
consent and goes on to subject transplantation and other medical practices to a strict licensing 
regime under a statutory regulator.  
The reform of this legislation illustrates one of the ways in which lawyers have led the 
transformation of bioethics from a professional matter to a highly regulated area of life. The 2004 
Act was prompted by a major inquiry into the retention of organs at Liverpool’s Alder Hey hospital. 
Chaired by Michael Redfern QC, it drew attention to the need for reform. Other examples of lawyers 
having a major impact in the area of health services include the many inquiries led by Sir Ian 
Kennedy, including most significantly that into children’s heart surgery at the Bristol Royal Infirmary, 
which led to a transformation of NHS culture partly consolidated by the NHS Reform and Health Care 
Professions Act 2002. Major change is expected as a result of the inquiry currently being undertaken 
into failures of care in Mid-Staffordshire, under the chairmanship of Robert Francis QC.  The NHS 
would be a very different place were it not for the work of lawyers. 
The leadership of lawyers has not been restricted to inquiries into scandals. Although bioethics 
flourished as a public enterprise after Kennedy’s Reith Lectures, the UK declined to take up his 
recommendation for a national bioethics commission on the US model. Nevertheless, a number of 
specific authorities were created to take work in this area forward and in many of them the 
contribution of lawyers was highly influential. When the Warnock Committee inquired into Human 
Fertilisation and Embryology in the early 1980s, the only legal members were the Vice-President of 
the Immigration Advisory Services (‘of whom we saw little, because we understood he was helping 
his clients in court’, Warnock Nature and Mortality (2004) p 84) and an Edinburgh solicitor (who was 
not mentioned at all in Warnock’s memoir of the discussions). It would be highly unlikely that any 
such committee would be set up today without a specialist in medical or health care law. 
Subsequent official inquiries into bioethical issues in reproduction have been headed by lawyers - 
Professor Margot Brazier of Manchester University (surrogacy) and Professor Sheila Maclean of the 
University of Glasgow (posthumous use of gametes). Alexander McCall Smith, now famous for his No 
1 Ladies Detective stories played his part too; as Professor of Medical Law at the University of 
Edinburgh and the first Vice-Chairman of the Human Genetics Commission. 
Lawyers can therefore be proud of the contribution their discipline has made to UK Bioethics, but in 
the future, they will need to be involved in a different ways. Under the current Coalition 
Government, the practice of bioethics is seeing a different kind of heat. In the glow of the ‘bonfire of 
the quangos’, choices need to be made about the future shape of bioethical governance. Lawyers 
will need to consider how to continue to influence thinking in new structures. Amongst the 
organisations scheduled to be disbanded are the Human Genetics Commission (to cease functioning 
at the end of March this year) and the Human Fertilisation and Embryology Authority, whose demise 
has been announced (although a spirited rear-guard action may yet save it). These organisations 
have been led by lawyers for substantial periods of their existence. Those with Oxford connections 
include two college principals: Baroness Helena Kennedy QC, who chaired the Human Genetics 
Commission from 1998-2007, and Baroness Ruth Deech who was chair of the Human Fertilisation 
and Embryology Authority from 1994-2002.  
In the new world of public bioethics, three main options would seem to present themselves for 
consideration. The first can be described as a personalisation of bioethics. In this model, the focus is 
on whether it is legitimate for the state, through the law, to regulate bioethics at all. Perhaps the law 
should retreat from this area of our lives. There may be reasons to protect ‘vulnerable’ patients 
against exploitation by commercial interests – as some argue are the key characteristics of assisted 
reproduction services or cosmetic surgery – but these are not bioethical concerns (about the 
appropriate use of scientific techniques) but consumer law matters. This raises a contemporary 
version of the famous debate between two eminent lawyers – Oxford Professor of Jurisprudence, 
HLA Hart and the Law Lord, Patrick Devlin (who graduated from Cambridge) -over the enforcement 
of morals. Some liberal views of the role of law might lead us to suppose that much of the subject 
area of bioethics is a private matter and not the legitimate province of jurisprudence. The majority 
report of the Select Committee of the House of Commons on Science and Technology on Human 
Reproductive Technologies and the Law (2004-5) seems to adopt this stance. Those who believe that 
bioethics is morally charged and a place in which the conflicts of values in modern society are being 
thrashed out, need to explain the justifications for regulating bioethical issues through the law (and, 
as a by-product, thereby secure the dominant role of lawyers in the field). 
A second model for the future of bioethics in the UK would be to drive it through Parliamentary 
processes. Some areas of bioethics, in particular abortion and euthanasia, regularly appear before 
legislators in the form of private members bills, although they rarely reach the statute book. More 
importantly for the development of bioethics policy are the committee inquiries. These both provide 
parliamentarians with an opportunity to set out policy proposals independently from Government 
and also enable members of the public and pressure groups (often comprising or assisted by lawyers) 
to contribute their views. The volumes of evidence to the House of Lords Select Committee on 
Medical Ethics (1993-4) provide a fascinating snapshot of views on the ethics of death and dying 
following the decision in Airedale NHS Trust v Bland [1993]. In the 2004-5 Session, the issue of 
Assisted Dying was thoroughly explored under the chairmanship of another lawyer, Lord Mackay of 
Clashfern and, again, the two volumes of evidence record the state of public debates over the issues. 
A standing Parliamentary Committee on Bioethics might be the way forward, and health care 
lawyers would have a good claim to take up roles as specialist advisors to such a committee. This 
approach has the advantage of a secure constitutional legitimacy in a democratic society but is 
prone to political pressures and the power of lobbyists. 
In a third model, the bioethics of the future will be led by what David Cameron has described as the 
‘Big Society’. This might be seen as the ‘privatisation’ of the enterprise of bioethics. Under this 
approach, bioethics remains of public importance rather than a matter of personal choice, but the 
opinion leaders are no longer sponsored by the state or part of its machinery of governance. A 
prominent illustration of this can be seen in the Commission on Assisted Dying, whose report was 
published in January 2012. The ‘commission’ in this case was not given by Government but by two 
private individuals, Bernard Lewis (founder of the River Island shopping chain) and Terry Pratchett 
(the celebrated author), both of whom were said to be in favour of liberalising the law to permit 
assisted suicide. The Commission was once again chaired by a lawyer, Lord Falconer. This 
development raises some new questions about legitimacy in public bioethics. Should we be 
suspicious of privately funded commissions because we fear that the views of funders will have 
disproportionately influenced the conclusions? Do public and transparent processes provide 
sufficient reassurance? Does the legitimacy of the reports of such commissions depend on those 
who choose to submit evidence? If so, have they inadvertently been seduced into strengthening the 
prospects of legal change by lending their authority to a private enterprise? 
This non-governmental option is less new than might appear. For many years prior to the 
domination of UK bioethics by Government sponsored commissions, work had been co-ordinated by 
health professional bodies such as the British Medical Association and the various Royal Colleges. 
Religious groups have also made some distinguished contributions, including the (now disbanded) 
Board for Social Responsibility of the Church of England. Questions about these groups’ legitimacy 
were obscured by the social authority that they already held, but in the culturally pluralist society in 
which UK bioethics must now function they need to be addressed. This is a challenge for the nearest 
the UK has to a standing commission – the Nuffield Council on Bioethics. This non-governmental 
body is funded by the Nuffield Foundation, the Wellcome Trust and the Medical Research Council 
and fiercely asserts its independence. The dominance of law is apparent in this body too - three of its 
five chairs have been lawyers. There is something of a paradox about the fact that despite the fact 
that UK governments have declined to institutionalise bioethics through a national commission in 
the way that many nations have now done, the impact of lawyers has been so significant. Law and 
bioethics have been knit closely together in the UK over the past thirty years but lawyers will need to 
adapt to the new structures if they are to retain their influence. 
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